NOTCH-mediated ex vivo expansion of human hematopoietic stem and progenitor cells by culture under hypoxia.


Journal

Stem cell reports
ISSN: 2213-6711
Titre abrégé: Stem Cell Reports
Pays: United States
ID NLM: 101611300

Informations de publication

Date de publication:
14 09 2021
Historique:
received: 11 12 2020
revised: 30 07 2021
accepted: 01 08 2021
pubmed: 28 8 2021
medline: 11 3 2022
entrez: 27 8 2021
Statut: ppublish

Résumé

Activation of NOTCH signaling in human hematopoietic stem/progenitor cells (HSPCs) by treatment with an engineered Delta-like ligand (DELTA1

Identifiants

pubmed: 34450041
pii: S2213-6711(21)00390-8
doi: 10.1016/j.stemcr.2021.08.001
pmc: PMC8452537
pii:
doi:

Substances chimiques

Antigens, CD34 0
Biomarkers 0
Receptors, Notch 0

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2336-2350

Subventions

Organisme : Intramural NIH HHS
ID : Z99 HL999999
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA HL006218
Pays : United States

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Blood. 2014 Jan 2;123(1):41-50
pubmed: 24243970
Stem Cells. 2007 Dec;25(12):3155-64
pubmed: 17761759
Blood. 2007 Oct 15;110(8):3056-63
pubmed: 17595331
Exp Cell Res. 2017 Jul 15;356(2):146-151
pubmed: 28456549
Cell Stem Cell. 2010 Aug 6;7(2):150-61
pubmed: 20682444
Nat Med. 2010 Feb;16(2):232-6
pubmed: 20081862
Cell Stem Cell. 2010 Sep 3;7(3):380-90
pubmed: 20804973
Biochem Biophys Res Commun. 2008 Feb 8;366(2):335-9
pubmed: 18047833
Blood. 2002 Apr 1;99(7):2369-78
pubmed: 11895769
Science. 2011 Nov 25;334(6059):1081-6
pubmed: 22116877
Cell Stem Cell. 2010 Aug 6;7(2):186-97
pubmed: 20619763
Nat Med. 2019 Oct;25(10):1566-1575
pubmed: 31591594
Immunity. 2003 May;18(5):699-711
pubmed: 12753746
Cell. 2015 Jun 18;161(7):1553-65
pubmed: 26073944
Science. 2015 Mar 20;347(6228):1374-7
pubmed: 25792330
Nat Immunol. 2013 Jul;14(7):756-63
pubmed: 23708252
Blood. 2014 Jan 9;123(2):203-7
pubmed: 24167196
Curr Opin Genet Dev. 2008 Oct;18(5):449-54
pubmed: 18722525
Exp Hematol. 2005 Jul;33(7):719-37
pubmed: 15963848
Stem Cell Rev Rep. 2012 Dec;8(4):1223-35
pubmed: 22628113
Nat Immunol. 2005 Mar;6(3):314-22
pubmed: 15665828
Nat Cell Biol. 2011 Mar;13(3):184-90
pubmed: 21364565
Cell Stem Cell. 2016 Jan 7;18(1):144-55
pubmed: 26669897
Cell Stem Cell. 2019 Nov 7;25(5):639-653.e7
pubmed: 31631013
Blood. 2005 Oct 15;106(8):2693-9
pubmed: 15976178
Nat Med. 2011 Aug 28;17(9):1086-93
pubmed: 21873988
Nature. 2014 Jun 12;510(7504):268-72
pubmed: 24776803
Development. 2014 Nov;141(22):4206-18
pubmed: 25371358
J Exp Med. 2003 Nov 3;198(9):1391-402
pubmed: 14597738
Nature. 2018 Jan 24;553(7689):418-426
pubmed: 29364285
Exp Hematol. 2002 Jul;30(7):816-23
pubmed: 12135681
Cell Rep. 2014 Jun 12;7(5):1381-1392
pubmed: 24882002
Blood. 2014 Nov 13;124(20):e45-8
pubmed: 25287706
Science. 1995 Apr 14;268(5208):225-32
pubmed: 7716513
Blood. 2017 Dec 21;130(25):2762-2773
pubmed: 29030335
J Clin Oncol. 2019 Feb 10;37(5):367-374
pubmed: 30523748
Blood. 2015 Sep 24;126(13):1631-3
pubmed: 26405217
Nature. 2003 Sep 18;425(6955):307-11
pubmed: 13679920
Cell. 2012 Feb 3;148(3):399-408
pubmed: 22304911
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Cell Stem Cell. 2013 Nov 7;13(5):549-63
pubmed: 24095676
Dev Cell. 2005 Nov;9(5):617-28
pubmed: 16256737
Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5431-6
pubmed: 17374716
Lancet Haematol. 2016 Jul;3(7):e330-9
pubmed: 27374466
Cell Rep. 2014 Aug 21;8(4):1077-92
pubmed: 25131208
Transfus Apher Sci. 2016 Jun;54(3):364-72
pubmed: 27211041
Stem Cells. 2007 May;25(5):1119-25
pubmed: 17255519
Cell Rep. 2018 Oct 30;25(5):1109-1117.e5
pubmed: 30380403
Blood. 2004 Apr 15;103(8):2942-9
pubmed: 15070669
Science. 2016 Apr 8;352(6282):189-96
pubmed: 27124452
Exp Mol Pathol. 2013 Feb;94(1):33-9
pubmed: 22964414
Cell Stem Cell. 2016 Apr 7;18(4):522-32
pubmed: 26831518
Mol Cell Biol. 2007 Mar;27(6):2092-102
pubmed: 17220275
Cell Stem Cell. 2010 Aug 6;7(2):174-85
pubmed: 20619762

Auteurs

Daisuke Araki (D)

Cellular and Molecular Therapeutics Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, MD 20892, USA.

Jian Fei Fu (JF)

Cellular and Molecular Therapeutics Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, MD 20892, USA.

Heather Huntsman (H)

Cellular and Molecular Therapeutics Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, MD 20892, USA.

Stefan Cordes (S)

Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD 20892, USA.

Fayaz Seifuddin (F)

Bioinformatics and Computational Biology Laboratory, NHLBI, NIH, Bethesda, MD 20892, USA.

Luigi J Alvarado (LJ)

Cellular and Molecular Therapeutics Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, MD 20892, USA.

Patali S Cheruku (PS)

Cellular and Molecular Therapeutics Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, MD 20892, USA.

Ayla Cash (A)

Cellular and Molecular Therapeutics Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, MD 20892, USA.

Javier Traba (J)

Cardiovascular Branch, NHLBI, NIH, Bethesda, MD 20892, USA.

Yuesheng Li (Y)

DNA Sequencing and Genomics Core Facility, NHLBI, NIH, Bethesda, MD 20892, USA.

Mehdi Pirooznia (M)

Bioinformatics and Computational Biology Laboratory, NHLBI, NIH, Bethesda, MD 20892, USA.

Richard H Smith (RH)

Cellular and Molecular Therapeutics Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, MD 20892, USA.

Andre Larochelle (A)

Cellular and Molecular Therapeutics Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, MD 20892, USA. Electronic address: larochea@nhlbi.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH